DAVID C. KOSEGARTEN, PH.D., R.PH.

Similar documents
Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi

Pharmacotherapy Handbook

Pharmacy Prep. Qualifying Pharmacy Review

nisterine Medications

Evaluating Exam Review Book and Guide

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition

comprehensive pharmacy review

NurseAchieve. CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NURSING SKILLS AND FUNDAMENTALS:

We are an academic institution What does that mean?

Diagnosis-specific morbidity - European shortlist

Clinical Pharmacology and Drug Therapy

Naples, Florida Hilton Naples

Pharmacology 260 Online Course Schedule Summer 2015

Prioritized ShortList MORBIDITY

HEALTH MATTERS, INC. SUMMARY OF PROJECTS AND KEY ACCOMPLISHMENTS TO 2016

CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

Welcome to Acute Care Preceptors Conference October 27 th 2009

MDB015/MPDP/001/04/04/2016 YALE/FPD ADVANCED HEALTH MANAGEMENT PROGRAMME (AHMP) 3 12 days - over 2 years 10 modules with 5 60 Ethical

Contributors. Thanks to Peter Miller, MD; LCDR Kevin Preston, MD; and Keith Newbrough, MD for their generous contribution of images:

Data Analysis with SPSS

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,

CHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Table of Contents. Course CME Credits. General Principles Topic CME Credit(s)

WITBANK COALFIELDS MEDICAL AID SCHEME (WCMAS) CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

Public Dissemination Effective: January 2018

CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER

Pharmacology for the Health Care Professions

comprehensive pharmacy review

DATE OF BIRTH: MELANOMA INTAKE

2009 PHARMACOTHERAPY PREPARATORY COURSE Program Faculty Affiliations and Learning Objectives

Mayo Clinic Physician Assistant Board Review

Pharmaceutical. Calculations

Member's Name RECOMMENDATION

RECOMMENDED COURSE ORDER

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #:

HOME DIALYSIS Pre-Assessment Form

Premium Specialty: Pediatrics

Chronic Obstructive Pulmonary Disease (COPD) Comorbidities Network

Selected tables standardised to Segi population

2016 General Practice/Family Practice Preferred Specialty Measure Set

Highland Colony Dental- Donald K. Givan, DMD

Inactive Occasional sports Work out 2-3x per week Work out 4-5x per week

NAME DATE Page 1. Other. Kidney Removed (Right, Left) Bladder Removed. Ovaries Removed for Endometriosis Breast Biopsy

Supplementary Appendix

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #:

REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

San Luis Dermatology & Laser Clinic, Inc.

Rationale for recommendations

Tamiflu. Tamiflu (oseltamivir) Description

2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives

Title: Dr/Mr/Mrs/Ms/Miss Last First M.I. Circle one. Primary Address: Street # Street name Apt# City State Zip

Patient Name (First, Middle, Last) Height Weight. Ethnicity Race Language. Address. City State Zip. Home Phone Cell Phone. Work Phone Other Phone

Jan. 12, 2017 FOR IMMEDIATE RELEASE

ALLERGIES 8. Have you ever had any allergic reaction (bad effect) to a medicine or shot?

PHO: Metadata for Mortality from Avoidable Causes

PLEASE COMPLETE ALL SECTIONS OF THIS FORM

Comprehensive Patient History Form

Student Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information

Patient Name: Date of Birth: Preferred Pharmacy: (name/location/phone #)

ECOND ANNUAL INTERNAL MEDICINE REVIEW October Ramee Grand Hotel 26 CME CREDITS. Renowned Speakers. Days Review Program ACCREDITED BY NHRA FOR

About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.

NEUROSURGERY PATIENT INTAKE FORM

Online appendix (Figures)

CHRONIC TREATMENT GUIDELINES

The Maudsley Prescribing Guidelines in

Psychotropic Drugs 0, 4-

Internal Medicine Certification Examination Blueprint

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL)

Pharmacy Orientation PP150. Associate professor of Pharmaceutics Faculty of Pharmacy-Mansoura University

Analgesic and NSAID-induced Kidney Disease

In your own words, please write the reason you are here. Please be specific, putting in dates as necessary. Use the back of the form if needed.

Duro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide)

Chapter 1: Certain Infectious and parasitic diseases (A00-B99)

USMLE STEP 2 CK REVIEW STUDY GUIDE

Patient Last Name First Name Middle Name. Home Address City State Zip. Date of Birth Age Social Security # - - Cell Phone Home Phone Work Phone

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

CONTENT OUTLINE FOR THE PHARMACOTHERAPY CERTIFICATION EXAMINATION

WORK PLAN FOR THE EFFICACY WORKING PARTY (EWP) CHAIRPERSON: Barbara van Zwieten-Boot

STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL

Primary Care Clinic Adult Patient Demographics

CHRONIC MEDICATION PROGRAMME INCLUDES PRESCRIBED MINIMUM BENEFIT CHRONIC DISEASE LIST (CDL)

Patient Name: Date of Birth:

ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives

Person Served Health Care Providers. Address Tel Number Fax

PROFMED MEDICAL SCHEME CHRONIC MEDICINE BENEFIT GENERAL INFORMATION

The World Health Organization (WHO) has classified pulmonary hypertension into five different groups: (3)

DERMATOLOGY & CUTANEOUS SURGERY. Welcome to the Department of Dermatology & Cutaneous Surgery!

THEORY: Modern Pharmaceutical Analytical Techniques (MPH-101) Drug Delivery System (MPH-102) Modern Pharmaceutics (MPH-103) Regulatory Affairs (MPH-10

Hospitalizations Entirely Caused by Alcohol: Appendices

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form

COUNTY OF MORRIS DEPARTMENT OF LAW & PUBLIC SAFETY OFFICE OF HEALTH MANAGEMENT

Evergreen Behavioral Health Psychiatric Intake Form. Name: Date: Date of Birth:!

M-II Class Schedule Spring 2018 Master Schedule (as of 12/15/2017)

Michael J. Huether, M.D., P.C. Arizona Skin Cancer Surgery Center, P.C. History and Intake Form. Patient Name D.O.

ADULT INFORMATION SHEET

Emergency Medicine Scope of Practice

COURSE OUTLINE Pathophysiology

Infectious Diseases Pharmacy Content Outline June 2017

Transcription:

MASTERING PHARMACY UCEIMSURE & CERTIFICATION A CASE-RASED REVIEW DAVID C. KOSEGARTEN, PH.D., R.PH. Associate Professor of Pharmacology and Toxicology Massachusetts College of Pharmacy and Health Sciences Boston, Massachusetts DOUGLAS J. PISANO, PH.D., R.PH. Associate Professor of Pharmacy Administration Massachusetts College of Pharmacy and Health Sciences Boston, Massachusetts F. RANDY VOGENBERG, PH.D., R.PH. Director and National Practice Leader ASA Health System Education and Pharmaceutical Consulting Wellesley, Massachusetts Deans' Professor of Pharmacy Management Philadelphia College of Pharmacy Philadelphia, Pennsylvania MCGRAW-HILL, INC. MEDICAL PUBLISHING DIVISION New York San Francisco Washington, D.C. Auckland Bogota Caracas Lisbon London Madrid Mexico City Milan Montreal New Delhi San Juan Singapore Sydney Tokyo Toronto

Contents 8 9 10 II 12 13 14 15 16 17 18 19 Part I Case Presentations and Questions Coronary Artery Disease Hypertension Seizure Disorders Buffer Solutions Bacteremia and Sepsis Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) Oncology/Breast Cancer Medicinal Chemistry Case #1 Panic Disorder Renal Transplantation Controlled Substances Act (C.S.A.) Arrhythmias Hypertension Seizure Disorders Antibiotic Suspensions Bacteremia and Sepsis Opportunistic Infections Oncology/Prostate Cancer Medicinal Chemistry Case #2 3 5 7 9 II 13 15 17 18 20 22 26 29 31 33 35 37 39 41

<L Contents 20 Generalized Anxiety Disorder 42 21 Renal Transplantation 44 22 Controlled Substances Act (C.S.A.) 47 23 Arrhythmias 49 24 Diabetes Mellitus 52 Nicole Turcotte 25 Seizure Disorders 54 26 Constitution and Flow Rates 56 27 Bacteremia and Sepsis 58 28 Sexually Transmitted Diseases 60 29 Oncology/Colon Cancer 62 30 Medicinal Chemistry Case #3 64 31 Major Depression 65 32 Renal Transplantation 67 33 Controlled Substances Act (C.S.A.) 69 34 Coronary Artery Disease 71 35 Diabetes Mellitus 74 36 Seizure Disorders 76 37 Radiopharmaceuticals 78 38 Bacteremia and Sepsis 80 39 Sexually Transmitted Diseases and Human Immunodeficiency Syndrome (HIV) 82

Contents XI 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Oncology/Lung Cancer Medicinal Chemistry Case #4 Major Depression Urinary Tract Infections Food, Drug, and Cosmetic Act (F.D.C.A.) Coronary Artery Disease Diabetes Mellitus Asthma Antacid Suspensions Respiratory Tract Infections Tuberculosis Oncology/Ovarian Cancer Medicinal Chemistry Case #5 Bipolar Disorder Urinary Tract Infections Food, Drug, and Cosmetic Act (F.D.C.A.) Coronary Artery Disease Asthma Ointments Respiratory Tract Infections Tuberculosis 84 86 87 89 91 93 95 97 99 101 104 106 108 109 III 114 117 120 122 124 126

XII Contents 61 Oncology/Lymphoma (Hodgkin's) 128 62 Medicinal Chemistry Case #6 130 63 Bipolar Disorder 131 64 Urinary Tract Infections 133 65 Prescription Drug Marketing Act (P.D.M.A.) 135 66 Coronary Artery Disease 137 67 Hypercholesterolemia 140 68 Asthma 142 69 Elixirs 144 70 Respiratory Tract Infections 146 71 Dermatology 148 72 Oncology/ALL (Pediatric) 150 73 Medicinal Chemistry Case #7 152 74 Schizophrenia 153 75 Parkinsons Disease 155 76 Mid-Level Practitioners 157 77 Congestive Heart Failure 158 78 Hypercholesterolemia 160 79 Asthma 162 80 Compounding Capsules 164 81 Soft Tissue Infections 166

Contents XIM 82 Dermatology/Acne 168 83 Oncology/CML (Adult) 170 84 Medicinal Chemistry Case #8 172 85 Schizophrenia 173 86 Parkinsons Disease 175 87 Poison Prevention Packaging Act (P.P.P.A.) 177 88 Congestive Heart Failure 178 89 Thyroid Disease 180 90 Chronic Obstructive Lung Disease 182 91 Parenteral Nutrition 184 92 Soft Tissue Infections 186 93 Osteoporosis 189 94 Oncology/Nausea and Vomiting Control 191 95 Medicinal Chemistry Case #9 193 96 Opiate Abuse 194 97 Parkinsons Disease 196 98 Expiration Dating and NDC Code 198 99 Arrhythmias 199 100 Thyroid Disease 202 101 Chronic Obstructive Lung Disease 204 102 Eye Drops 206

XIV Contents 103 Soft Tissue Infections 104 Osteoporosis 105 Oncology/Pain Control 106 Medicinal Chemistry Case #10 107 Alcohol Abuse 108 Over-the-Counter Drugs 109 Congestive Heart Failure/Arrhythmias 110 Thyroid Disease 111 Chronic Obstructive Lung Disease 112 Arrhythmias 113 Hypertension 114 Hypertension Down Chandler-Toufieli 115 Hypertension 116 Anticoagulation 117 Anticoagulation 118 Anticoagulation 119 Hypercholesterolemia 120 Hypercholesterolemia Part II Answers with Explanations and Answers Appendix Subject Index References 208 210 212 214 215 217 219 222 224 226 228 230 232 234 236 238 240 242 247 339 355